Redirecting to original paper in 30 seconds...
Click below to go immediately or wait for automatic redirect
📄 Abstract
Abstract: Retrosynthesis plays a crucial role in the fields of organic synthesis and
drug development, where the goal is to identify suitable reactants that can
yield a target product molecule. Although existing methods have achieved
notable success, they typically overlook the 3D conformational details and
internal spatial organization of molecules. This oversight makes it challenging
to predict reactants that conform to genuine chemical principles, particularly
when dealing with complex molecular structures, such as polycyclic and
heteroaromatic compounds. In response to this challenge, we introduce a novel
transformer-based, template-free approach that incorporates 3D conformer data
and spatial information. Our approach includes an Atom-align Fusion module that
integrates 3D positional data at the input stage, ensuring correct alignment
between atom tokens and their respective 3D coordinates. Additionally, we
propose a Distance-weighted Attention mechanism that refines the self-attention
process, constricting the model s focus to relevant atom pairs in 3D space.
Extensive experiments on the USPTO-50K dataset demonstrate that our model
outperforms previous template-free methods, setting a new benchmark for the
field. A case study further highlights our method s ability to predict
reasonable and accurate reactants.
Authors (5)
Jiaxi Zhuang
Yu Zhang
Yan Zhang
Ying Qian
Aimin Zhou
Submitted
January 21, 2025
Key Contributions
Retro3D introduces a novel 3D-aware, template-free method for retrosynthesis that explicitly incorporates molecular conformer information and spatial organization. By using an Atom-align Fusion module and Distance-weighted Attention, it addresses the limitations of existing methods that overlook 3D details, leading to more chemically accurate reactant predictions, especially for complex molecules.
Business Value
Accelerates drug discovery and development by improving the efficiency and accuracy of identifying synthetic routes for novel molecules, potentially reducing R&D costs and time-to-market for new pharmaceuticals.